MICHELLE TAVENER: Open Payments
NPI 1962689406 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 29 payments from 17 companies in 2025. Trend: 2023 $167 · 2024 $560 · 2025 $1,090
Food & beverage: $1,033Education: $56
| Company | Payments | Amount |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 3 | $273 |
| Mallinckrodt Hospital Products Inc. | 2 | $146 |
| Travere Therapeutics, Inc. | 1 | $136 |
| ABIOMED | 1 | $67 |
| OPKO Pharmaceuticals, LLC | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Novo Nordisk Inc | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Amgen Inc. | 2 | $42 |
Products named: ACTHAR, Filspari, DUPIXENT, RAYALDEE, Fabhalta, Kerendia, KRYSTEXXA, Rybelsus.
Industry payments across NV — which companies pay providers there.
